DaVita Inc. (DVA)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
101.66+1.07 (+1.06%)
At close: 4:00PM EST
| Previous close | 100.59 |
| Open | 100.57 |
| Bid | 100.44 x 900 |
| Ask | 102.70 x 900 |
| Day's range | 99.84 - 102.31 |
| 52-week range | 96.98 - 136.48 |
| Volume | 834,130 |
| Avg. volume | 767,828 |
| Market cap | 10.796B |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | 15.71 |
| EPS (TTM) | 6.47 |
| Earnings date | 09 Feb 2022 - 14 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 142.88 |
- Zacks
New Strong Sell Stocks for November 19th
AMED, CSII, DVA, GFF, and LTRX have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2021.
- Zacks
New Strong Sell Stocks for November 3rd
TEAM, DVA, FLS, JD, and SBUX have been added to the Zacks Rank #5 (Strong Sell) List on November 3, 2021.
- Zacks
DaVita (DVA) Beats on Q3 Earnings, Narrows 2021 EPS View
DaVita's (DVA) strength in dialysis patient service revenues drives its Q3 top line.
© 2021 Yahoo. All rights reserved.
